Dr. Reddy's Laboratories Limited (DRREDDY.NS)
INR 1109.95
(-3.6%)
INR 1109.95
(-3.6%)
| Year | Long Term Debt | Long Term Debt Growth |
|---|---|---|
| 2023 | 5.99 Billion INR | 368.7% |
| 2022 | 1.27 Billion INR | -77.76% |
| 2021 | 5.74 Billion INR | -8.78% |
| 2020 | 6.29 Billion INR | 383.05% |
| 2019 | 1.3 Billion INR | -94.07% |
| 2018 | 22 Billion INR | -12.31% |
| 2017 | 25.08 Billion INR | 360.43% |
| 2016 | 5.44 Billion INR | -49.0% |
| 2015 | 10.68 Billion INR | -25.32% |
| 2014 | 14.3 Billion INR | -31.02% |
| 2013 | 20.74 Billion INR | -83.57% |
| 2012 | 126.24 Billion INR | 672.86% |
| 2011 | 16.33 Billion INR | 207.28% |
| 2010 | 5.31 Billion INR | -1.28% |
| 2009 | 5.38 Billion INR | -46.85% |
| 2008 | 10.13 Billion INR | -21.24% |
| 2007 | 12.86 Billion INR | -28.19% |
| 2006 | 17.91 Billion INR | -14.66% |
| 2005 | 20.99 Billion INR | 83354.69% |
| 2004 | 25.15 Million INR | -19.25% |
| 2003 | 31.14 Million INR | -23.66% |
| 2002 | 40.8 Million INR | -13.13% |
| 2001 | 46.97 Million INR | -95.3% |
| 2000 | 999.73 Million INR | 0.0% |
| Year | Long Term Debt | Long Term Debt Growth |
|---|---|---|
| 2024 Q2 | 7.36 Billion INR | 0.0% |
| 2024 Q1 | 3.8 Billion INR | 0.0% |
| 2023 Q3 | 6.15 Billion INR | 1.8% |
| 2023 Q2 | 6.04 Billion INR | 22.58% |
| 2023 FY | 5.99 Billion INR | 368.7% |
| 2023 Q4 | 5.99 Billion INR | -2.63% |
| 2023 Q1 | 4.93 Billion INR | 285.76% |
| 2022 Q4 | 1.27 Billion INR | -12.29% |
| 2022 FY | 1.27 Billion INR | -77.76% |
| 2022 Q3 | 1.45 Billion INR | -18.83% |
| 2022 Q1 | 1.9 Billion INR | -66.88% |
| 2022 Q2 | 1.79 Billion INR | -5.68% |
| 2021 Q2 | 5.97 Billion INR | -3.07% |
| 2021 FY | 5.74 Billion INR | -8.78% |
| 2021 Q1 | 6.16 Billion INR | -2.11% |
| 2021 Q4 | 5.74 Billion INR | -4.76% |
| 2021 Q3 | 6.03 Billion INR | 0.94% |
| 2020 Q3 | 6.5 Billion INR | -2.3% |
| 2020 Q4 | 6.29 Billion INR | -3.21% |
| 2020 FY | 6.29 Billion INR | 383.05% |
| 2020 Q1 | 6.78 Billion INR | 420.63% |
| 2020 Q2 | 6.66 Billion INR | -1.89% |
| 2019 Q2 | 15.28 Billion INR | -8.24% |
| 2019 Q3 | 1.24 Billion INR | -91.85% |
| 2019 FY | 1.3 Billion INR | -94.07% |
| 2019 Q4 | 1.3 Billion INR | 4.65% |
| 2019 Q1 | 16.65 Billion INR | -24.29% |
| 2018 Q2 | 27.59 Billion INR | 5.75% |
| 2018 Q1 | 26.09 Billion INR | 4.02% |
| 2018 Q4 | 22 Billion INR | -10.93% |
| 2018 Q3 | 24.7 Billion INR | -10.5% |
| 2018 FY | 22 Billion INR | -12.31% |
| 2017 Q4 | 25.08 Billion INR | 2.57% |
| 2017 FY | 25.08 Billion INR | 360.43% |
| 2017 Q3 | 24.46 Billion INR | -1.97% |
| 2017 Q2 | 24.95 Billion INR | 1.6% |
| 2017 Q1 | 24.56 Billion INR | 350.72% |
| 2016 Q3 | 5.71 Billion INR | -46.45% |
| 2016 Q2 | 10.67 Billion INR | -1.57% |
| 2016 Q4 | 5.44 Billion INR | -4.69% |
| 2016 Q1 | 10.84 Billion INR | 1.52% |
| 2016 FY | 5.44 Billion INR | -49.0% |
| 2015 Q2 | 10.63 Billion INR | -12.01% |
| 2015 Q4 | 10.68 Billion INR | -0.07% |
| 2015 Q1 | 12.08 Billion INR | -15.54% |
| 2015 FY | 10.68 Billion INR | -25.32% |
| 2015 Q3 | 10.69 Billion INR | 0.56% |
| 2014 FY | 14.3 Billion INR | -31.02% |
| 2014 Q3 | 16.43 Billion INR | -8.13% |
| 2014 Q2 | 17.88 Billion INR | -6.86% |
| 2014 Q1 | 19.2 Billion INR | -7.41% |
| 2014 Q4 | 14.3 Billion INR | -12.93% |
| 2013 Q3 | 22.99 Billion INR | -8.36% |
| 2013 Q1 | 13.84 Billion INR | -89.03% |
| 2013 Q4 | 20.74 Billion INR | -9.81% |
| 2013 Q2 | 25.09 Billion INR | 81.28% |
| 2013 FY | 20.74 Billion INR | -83.57% |
| 2012 FY | 126.24 Billion INR | 672.86% |
| 2012 Q4 | 126.24 Billion INR | 628.78% |
| 2012 Q2 | 16.82 Billion INR | -3.3% |
| 2012 Q1 | 17.39 Billion INR | 6.51% |
| 2012 Q3 | 17.32 Billion INR | 2.97% |
| 2011 FY | 16.33 Billion INR | 207.28% |
| 2011 Q4 | 16.33 Billion INR | -2.83% |
| 2011 Q3 | 16.81 Billion INR | 217.55% |
| 2011 Q2 | 5.29 Billion INR | 0.15% |
| 2011 Q1 | 5.28 Billion INR | -0.56% |
| 2010 Q1 | 4.22 Billion INR | -21.52% |
| 2010 Q3 | 233 Million INR | -90.18% |
| 2010 Q4 | 5.31 Billion INR | 2181.55% |
| 2010 FY | 5.31 Billion INR | -1.28% |
| 2010 Q2 | 2.37 Billion INR | -43.87% |
| 2009 Q3 | 6.97 Billion INR | -16.48% |
| 2009 Q1 | 16.1 Billion INR | 58.98% |
| 2009 Q4 | 5.38 Billion INR | -22.75% |
| 2009 Q2 | 8.34 Billion INR | -48.18% |
| 2009 FY | 5.38 Billion INR | -46.85% |
| 2008 FY | 10.13 Billion INR | -21.24% |
| 2008 Q4 | 10.13 Billion INR | -9.83% |
| 2008 Q1 | 12.83 Billion INR | -0.23% |
| 2008 Q2 | 11.96 Billion INR | -6.74% |
| 2008 Q3 | 11.23 Billion INR | -6.11% |
| 2007 Q4 | 12.86 Billion INR | 5.55% |
| 2007 Q3 | 12.18 Billion INR | -0.8% |
| 2007 Q2 | 12.28 Billion INR | -0.92% |
| 2007 Q1 | 12.4 Billion INR | -30.78% |
| 2007 FY | 12.86 Billion INR | -28.19% |
| 2006 Q3 | 15.36 Billion INR | -25.16% |
| 2006 Q4 | 17.91 Billion INR | 16.55% |
| 2006 Q1 | 21.76 Billion INR | 3.67% |
| 2006 FY | 17.91 Billion INR | -14.66% |
| 2006 Q2 | 20.53 Billion INR | -5.63% |
| 2005 FY | 20.99 Billion INR | 83354.69% |
| 2005 Q3 | 20.71 Million INR | -6.69% |
| 2005 Q4 | 20.99 Billion INR | 101246.54% |
| 2005 Q1 | 23.65 Million INR | -5.97% |
| 2005 Q2 | 22.19 Million INR | -6.15% |
| 2004 Q4 | 25.15 Million INR | 2.57% |
| 2004 FY | 25.15 Million INR | -19.25% |
| 2004 Q1 | 29.56 Million INR | -5.09% |
| 2004 Q3 | 24.52 Million INR | -12.79% |
| 2004 Q2 | 28.11 Million INR | -4.88% |
| 2003 Q1 | 34.41 Million INR | -15.65% |
| 2003 Q4 | 31.14 Million INR | -0.56% |
| 2003 Q2 | 32.86 Million INR | -4.53% |
| 2003 Q3 | 31.32 Million INR | -4.67% |
| 2003 FY | 31.14 Million INR | -23.66% |
| 2002 FY | 40.8 Million INR | -13.13% |
| 2002 Q3 | 184.5 Million INR | 0.32% |
| 2002 Q4 | 40.8 Million INR | -77.88% |
| 2002 Q1 | 173.72 Million INR | 269.85% |
| 2002 Q2 | 183.91 Million INR | 5.86% |
| 2001 FY | 46.97 Million INR | -95.3% |
| 2001 Q1 | 45.57 Million INR | 0.0% |
| 2001 Q2 | 45.72 Million INR | 0.34% |
| 2001 Q4 | 46.97 Million INR | 3.91% |
| 2001 Q3 | 45.2 Million INR | -1.14% |
| 2000 FY | 999.73 Million INR | 0.0% |
| Name | Long Term Debt | Long Term Debt Difference |
|---|---|---|
| Aarti Drugs Limited | 2.75 Billion INR | -117.557% |
| Aarti Pharmalabs Limited | 400 Thousand INR | -1497400.0% |
| Albert David Limited | 6.01 Million INR | -99467.819% |
| Alembic Pharmaceuticals Limited | 628.8 Million INR | -852.608% |
| Bafna Pharmaceuticals Limited | 107.53 Million INR | -5470.435% |
| Biofil Chemicals and Pharmaceuticals Limited | - INR | -Infinity% |
| FDC Limited | 2.46 Million INR | -242803.487% |
| Gufic Biosciences Limited | 1.53 Billion INR | -289.054% |
| Hikal Limited | 4.22 Billion INR | -41.658% |
| Ind-Swift Laboratories Limited | 111.62 Million INR | -5266.133% |
| Ind-Swift Limited | 10.09 Billion INR | 40.664% |
| Jubilant Pharmova Limited | 31.67 Billion INR | 81.087% |
| Lincoln Pharmaceuticals Limited | - INR | -Infinity% |
| Mangalam Drugs & Organics Limited | 133.54 Million INR | -4385.514% |
| Medico Remedies Limited | 8.67 Million INR | -68972.878% |
| Morepen Laboratories Limited | 33.64 Million INR | -17706.183% |
| Nectar Lifesciences Limited | 1.4 Billion INR | -326.916% |
| Orchid Pharma Limited | 1.2 Billion INR | -397.385% |
| Procter & Gamble Health Limited | 68.8 Million INR | -8606.395% |
| RPG Life Sciences Limited | -30.3 Million INR | 19868.977% |
| Alembic Limited | 73.9 Million INR | -8005.548% |
| Alkem Laboratories Limited | 400 Million INR | -1397.5% |
| Bajaj HealthCare Limited | 650.34 Million INR | -821.05% |
| Brooks Laboratories Limited | 3.56 Million INR | -167922.44% |
| Eris Lifesciences Limited | 6.54 Billion INR | 8.481% |
| Glenmark Life Sciences Limited | 147.61 Million INR | -3957.991% |
| Sigachi Industries Limited | 265.79 Million INR | -2153.591% |
| Solara Active Pharma Sciences Limited | 1.17 Billion INR | -410.048% |
| Sun Pharmaceutical Industries Limited | 13.3 Million INR | -44937.594% |
| Innova Captab Limited | 2.1 Billion INR | -184.534% |
| IOL Chemicals and Pharmaceuticals Limited | - INR | -Infinity% |
| Suven Pharmaceuticals Limited | 212.35 Million INR | -2720.735% |
| Jagsonpal Pharmaceuticals Limited | 75.57 Million INR | -7826.426% |
| Themis Medicare Limited | 267.74 Million INR | -2137.245% |
| Unichem Laboratories Limited | 382.22 Million INR | -1467.156% |
| Vaishali Pharma Limited | 35.98 Million INR | -16546.75% |
| Venus Remedies Limited | 386.8 Million INR | -1448.604% |
| Wanbury Limited | 820 Million INR | -630.488% |
| Windlas Biotech Limited | 20.18 Million INR | -29582.854% |
| ZIM Laboratories Limited | 356 Million INR | -1582.556% |
| Kilitch Drugs (India) Limited | - INR | -Infinity% |
| Lupin Limited | 1.55 Billion INR | -285.755% |
| Sakar Healthcare Limited | 549.55 Million INR | -989.983% |
| Aurobindo Pharma Limited | 21.34 Billion INR | 71.942% |
| Divi's Laboratories Limited | 20 Million INR | -29850.0% |
| AstraZeneca Pharma India Limited | 27.83 Million INR | -21418.896% |
| Mankind Pharma Limited | 325.81 Million INR | -1738.467% |
| Sequent Scientific Limited | 1.42 Billion INR | -319.706% |
| Laurus Labs Limited | 7.98 Billion INR | 24.959% |
| Neuland Laboratories Limited | 449.2 Million INR | -1233.464% |
| J. B. Chemicals & Pharmaceuticals Limited | 236.4 Million INR | -2433.841% |
| Glenmark Pharmaceuticals Limited | 1.51 Billion INR | -294.882% |
| Zydus Lifesciences Limited | 251 Million INR | -2286.454% |
| Amrutanjan Health Care Limited | 13.96 Million INR | -42783.734% |
| Wockhardt Limited | 8.91 Billion INR | 32.772% |
| Bal Pharma Limited | 363.82 Million INR | -1546.4% |
| Bliss GVS Pharma Limited | 355.92 Million INR | -1582.953% |
| Par Drugs and Chemicals Limited | - INR | -Infinity% |
| Caplin Point Laboratories Limited | 9.2 Million INR | -65008.696% |
| Shilpa Medicare Limited | 5.6 Billion INR | -6.934% |
| Valiant Laboratories Limited | 750.89 Million INR | -697.71% |
| Ajanta Pharma Limited | 235.2 Million INR | -2446.769% |
| Hester Biosciences Limited | 1.81 Billion INR | -229.532% |
| Aarey Drugs & Pharmaceuticals Limited | 32.24 Million INR | -18477.234% |
| Granules India Limited | 689.71 Million INR | -768.481% |
| Medicamen Biotech Limited | 12.55 Million INR | -47610.076% |
| Ipca Laboratories Limited | 5.8 Billion INR | -3.203% |
| Syncom Formulations (India) Limited | -1.21 Million INR | 491486.382% |
| Piramal Enterprises Limited | 535.85 Billion INR | 98.882% |
| Torrent Pharmaceuticals Limited | 16.04 Billion INR | 62.656% |
| NATCO Pharma Limited | 53 Million INR | -11201.887% |
| Suven Life Sciences Limited | - INR | -Infinity% |
| Krebs Biochemicals & Industries Limited | 1.83 Billion INR | -226.431% |
| Strides Pharma Science Limited | 6.71 Billion INR | 10.797% |
| Indoco Remedies Limited | 3.51 Billion INR | -70.301% |
| Alpa Laboratories Limited | - INR | -Infinity% |
| Lasa Supergenerics Limited | - INR | -Infinity% |
| Sun Pharma Advanced Research Company Limited | 106.6 Million INR | -5519.137% |